View Cart  

Watson to Market Generic Avapro

A A
Watson plans to immediately begin shipping its generic versions of Sanofi’s hypertension treatment Avapro after receiving FDA approval to market the generic version. Watson will have a slew of generic competitors for irbesartan, including Lupin, which received ANDA approval Oct. 15, Mylan, Sandoz, Teva and Dr. Reddy’s. Watson will offer the 75-mg, 150-mg and 300-mg versions of the drug.
Generic Line